Impact of Cardiovascular Risk Factors on the Occurrence of Cardiovascular Events in Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitides
Despite improvement in the prognosis of ANCA-associated vasculitides (AAVs), increased mortality, mainly from a cardiovascular origin, persists. We aimed to determine the role of cardiovascular risk factors (CVRFs) on the occurrence of major cardiovascular events (MACEs) in AAVs. Patients with AAVs...
Main Authors: | Camille Roubille, Soledad Henriquez, Cédric Mercuzot, Claire Duflos, Bertrand Dunogue, Karine Briot, Loic Guillevin, Benjamin Terrier, Pierre Fesler |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/11/2299 |
Similar Items
-
Cost-minimization analysis of individually tailored or fixed-scheduled rituximab maintenance therapy for antineutrophil-cytoplasm antibody associated vasculitides
by: Ana Belén Guisado-Gil, et al.
Published: (2020-03-01) -
Treatment of renal ANCA-associated vasculitides
by: Olumide Olatubosun Rowaiye, et al.
Published: (2016-06-01) -
ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS IN “REAL LIFE” – SERIES OF CLINICAL CASES IN A ROMANIAN REFERENCE CENTER
by: Mihaela-Lavinia Popescu, et al.
Published: (2017-12-01) -
A case of propylthiouracil-induced antineutrophilic cytoplasmic antibody-positive vasculitis successfully treated with radioactive iodine
by: C. Bes, et al.
Published: (2013-07-01) -
Antineutrophil cytoplasmic autoantibody (ANCA) positive immunoglobulin A (IgA) nephropathy: Case reports and review of literature
by: Natalia Chebotareva, et al.
Published: (2020-07-01)